These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical Impact of Muscle Quantity and Quality in Colorectal Cancer Patients: A Propensity Score Matching Analysis. Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Yin C; Narumi A; Omura Y; Ide S; Kitajima T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Kobayashi M; Araki T; McMillan DC; Miki C; Kusunoki M JPEN J Parenter Enteral Nutr; 2018 Nov; 42(8):1322-1333. PubMed ID: 29761898 [TBL] [Abstract][Full Text] [Related]
4. Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer. Hur K; Toiyama Y; Okugawa Y; Ide S; Imaoka H; Boland CR; Goel A Gut; 2017 Apr; 66(4):654-665. PubMed ID: 26701878 [TBL] [Abstract][Full Text] [Related]
5. Up-regulation of miR-592 correlates with tumor progression and poor prognosis in patients with colorectal cancer. Liu M; Zhi Q; Wang W; Zhang Q; Fang T; Ma Q Biomed Pharmacother; 2015 Feb; 69():214-20. PubMed ID: 25661360 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study. Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286 [TBL] [Abstract][Full Text] [Related]
8. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer. Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer. Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755 [TBL] [Abstract][Full Text] [Related]
10. Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation. Hamaguchi Y; Kaido T; Okumura S; Fujimoto Y; Ogawa K; Mori A; Hammad A; Tamai Y; Inagaki N; Uemoto S Liver Transpl; 2014 Nov; 20(11):1413-9. PubMed ID: 25088484 [TBL] [Abstract][Full Text] [Related]
11. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer. Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y Oncology; 2017; 92(6):360-370. PubMed ID: 28376502 [TBL] [Abstract][Full Text] [Related]
12. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer. Lv ZC; Fan YS; Chen HB; Zhao DW Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214 [TBL] [Abstract][Full Text] [Related]
13. Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Okumura S; Kaido T; Hamaguchi Y; Fujimoto Y; Masui T; Mizumoto M; Hammad A; Mori A; Takaori K; Uemoto S Surgery; 2015 Jun; 157(6):1088-98. PubMed ID: 25799468 [TBL] [Abstract][Full Text] [Related]
14. Serum level of miR-142-3p predicts prognostic outcome for colorectal cancer following curative resection. Gao W; Pang D; Yu S J Int Med Res; 2019 May; 47(5):2116-2125. PubMed ID: 30922137 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer. Li J; Chen Y; Guo X; Zhou L; Jia Z; Tang Y; Lin L; Liu W; Ren C Tumour Biol; 2016 Jul; 37(7):8765-73. PubMed ID: 26743779 [TBL] [Abstract][Full Text] [Related]
16. Close Relationship Between Immunological/Inflammatory Markers and Myopenia and Myosteatosis in Patients With Colorectal Cancer: A Propensity Score Matching Analysis. Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Kitamura A; Ichikawa T; Ide S; Kitajima T; Fujikawa H; Yasuda H; Okita Y; Hiro J; Araki T; McMillan DC; Miki C; Kusunoki M JPEN J Parenter Enteral Nutr; 2019 May; 43(4):508-515. PubMed ID: 30334265 [TBL] [Abstract][Full Text] [Related]
17. Impact of Preoperative Skeletal Muscle Mass and Quality on the Survival of Elderly Patients After Curative Resection of Colorectal Cancer. Ojima Y; Harano M; Sumitani D; Okajima M J Anus Rectum Colon; 2019; 3(4):143-151. PubMed ID: 31768464 [TBL] [Abstract][Full Text] [Related]
18. Low expression of microRNA-126 is associated with poor prognosis in colorectal cancer. Liu Y; Zhou Y; Feng X; Yang P; Yang J; An P; Wang H; Ye S; Yu C; He Y; Luo H Genes Chromosomes Cancer; 2014 Apr; 53(4):358-65. PubMed ID: 24532280 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of miR-199b is associated with distant metastasis in colorectal cancer via activation of SIRT1 and inhibition of CREB/KISS1 signaling. Shen ZL; Wang B; Jiang KW; Ye CX; Cheng C; Yan YC; Zhang JZ; Yang Y; Gao ZD; Ye YJ; Wang S Oncotarget; 2016 Jun; 7(23):35092-105. PubMed ID: 27145368 [TBL] [Abstract][Full Text] [Related]
20. Modified intramuscular adipose tissue content as a feasible surrogate marker for malnutrition in gastrointestinal cancer. Kusunoki Y; Okugawa Y; Toiyama Y; Kusunoki K; Ichikawa T; Ide S; Shimura T; Kitajima T; Imaoka H; Fujikawa H; Yasuda H; Yokoe T; Okita Y; Mochiki I; Ohi M; McMillan DC; Nakatani K; Kusunoki M Clin Nutr; 2021 May; 40(5):2640-2653. PubMed ID: 33933730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]